Physician profile
Michael Patrick Oquinn
NPI 1073807541
$70,284.00
in general payments reported to CMS, 2019-2025
38 companies · $1,874 in 2025
The $1,874 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $16K · 2021: $3,559 · 2022: $8,572 · 2023: $9,711 · 2024: $1,698 · 2025: $1,874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,095 · Travel and Lodging: $4,189 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,094.55 |
| Travel and Lodging | $4,188.97 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $29,574.61 | 2019-2020 | |
| Biotronik INC. | $19,295.12 | 2020-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Cardiofocus, INC. | $7,068.13 | 2020-2022 | |
| Boston Scientific Corporation | $4,209.49 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Atricure, INC. | $2,878.89 | 2021-2024 | |
| Abbott Laboratories | $1,513.51 | 2019-2025 | Amplatzer Amulet, Ensite, Quadra Allure Mp |
| Biosense Webster, INC. | $1,146.94 | 2021-2024 | Carto 3 |
| Medical Device Business Services, INC. | $725.87 | 2022-2023 | Carto 3 |
| Medtronic, INC. | $696.45 | 2021-2025 | Azure Xt Dr Mri Surescan, Sphere-9, Onyx Frontier |
| Cms Imaging, INC. | $367.61 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $341.28 | 2019-2023 | Lifevest |
| Impulse Dynamics (USA) INC. | $331.72 | 2022-2025 | Optimizer, Optimizer |
| Vektor Medical INC. | $251.64 | 2025 | |
| Novartis Pharmaceuticals Corporation | $241.38 | 2021-2023 | |
| Cardiva Medical, INC. | $168.84 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $142.40 | 2021-2025 | |
| Cardiovascular Systems INC. | $124.87 | 2020-2022 | |
| Astrazeneca Pharmaceuticals Lp | $115.74 | 2020-2023 | Andexxa |
| Cordis US Corp. | $114.16 | 2025 | Mynx Control Venous |
| Cvrx, INC. | $112.39 | 2023-2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $106.93 | 2023-2024 | Xarelto |
| Asahi Intecc USA, INC. | $100.00 | 2021 | |
| Abiomed | $87.39 | 2023-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $72.59 | 2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $72.26 | 2021-2023 | Verquvo |
| Inari Medical, INC. | $70.18 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.68 | 2022-2024 | Jardiance |
| Chiesi USA, INC. | $47.54 | 2022 | |
| Angiodynamics, INC. | $46.92 | 2023 | Alphavac |
| Philips North America LLC | $39.06 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Recor Medical INC | $24.93 | 2024 | Paradise Renal Denervation System |
| Amgen INC. | $24.56 | 2022-2023 | Repatha |
| Edwards Lifesciences Corporation | $20.70 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Actelion Pharmaceuticals US, INC. | $19.57 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $18.49 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2025 | |
| Getinge USA Sales, LLC | $14.71 | 2021 | |
| Terumo Medical Corporation | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Oquinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.